Denali Therapeutics Inc. (DNLI)
Today's Latest Price: $61.27 USD
Updated Nov 27 1:00pm
Add DNLI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
Denali Therapeutics Inc (DNLI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering DNLI.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 9 | $81 | $18 | $61.44 | $60.62 | 1.35% |
DNLI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.36 | 7 | 0 | 4 | 0 | 0 | 11 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Denali Therapeutics Inc's percent of analysts bearish on the stock is lower than nearly 100% of all US stocks.
- The variance in analysts' estimates of DNLI is less than 4.56% of stocks in the mid market cap category.
- DNLI has a greater upside potential (average analyst target price relative to current price) than 9.65% of Pharmaceutical Products stocks.
- Denali Therapeutics Inc's average analyst price target is higher than 84.21% of Pharmaceutical Products stocks.
- DNLI has a higher number of analysts covering the stock than 78.25% of Pharmaceutical Products stocks.
- The percentage of analysts bullish on the stock of DNLI is greater than 26.91% of Pharmaceutical Products stocks.
- DNLI has a lower change in bullishness amongst analysts than nearly 100% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Denali Therapeutics Inc are BNTX, ZGNX and SGMO.
Is DNLI a Buy, Hold or Sell? See the POWR Ratings now!
